Clinical trial
Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance
NCT02730390 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical, Inc., Philippines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance
- Lead sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- August 31, 2013
- Enrollment
- 3,087 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hyperlipidemia